Search Results - "Orleth, Annette"
-
1
Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth
Published in Clinical cancer research (15-01-2012)“…Angiogenesis is a key process in tumor progression. By binding VEGF, VEGF receptor-2 (VEGFR2) is a main signaling transducer in tumor-associated angiogenesis…”
Get full text
Journal Article -
2
MultiSCRIPT-Cycle 1-a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial
Published in Current controlled trials in cardiovascular medicine (11-09-2024)“…Treatment decisions for persons with relapsing-remitting multiple sclerosis (RRMS) rely on clinical and radiological disease activity, the benefit-harm profile…”
Get full text
Journal Article -
3
Generating evidence on a risk-based monitoring approach in the academic setting - lessons learned
Published in BMC medical research methodology (14-02-2017)“…In spite of efforts to employ risk-based strategies to increase monitoring efficiency in the academic setting, empirical evidence on their effectiveness…”
Get full text
Journal Article -
4
Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair
Published in The Journal of clinical investigation (01-12-2003)Get full text
Journal Article -
5
Common themes in the pathogenesis of acute myeloid leukemia
Published in Oncogene (10-09-2001)“…The pathogenesis of acute myeloid leukemia is associated with the appearance of oncogenic fusion proteins generated as a consequence of specific chromosome…”
Get full text
Journal Article -
6
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
Published in JAMA neurology (01-03-2023)“…There is a lack of validated biomarkers for disability progression independent of relapse activity (PIRA) in multiple sclerosis (MS). To determine how serum…”
Get more information
Journal Article -
7
Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS (P9-14.004)
Published in Neurology (09-04-2024)“…Abstract only…”
Get full text
Journal Article -
8
PAX5 Expression in Acute Leukemias
Published in Cancer research (Chicago, Ill.) (15-10-2004)“…Abstract The transcription factor PAX5 plays a key role in the commitment of hematopoietic precursors to the B-cell lineage, but its expression in acute…”
Get full text
Journal Article -
9
The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodies
Published in Oncogene (16-04-1998)“…Acute promyelocytic leukaemia is characterized by translocations that involve the retinoic acid receptor alpha (RAR alpha) locus on chromosome 17 and the PML…”
Get full text
Journal Article -
10
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells
Published in Nature (01-01-2009)“…Rare cells with the properties of stem cells are integral to the development and perpetuation of leukaemias. A defining characteristic of stem cells is their…”
Get full text
Journal Article -
11
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS
Published in Annals of neurology (01-06-2022)“…Objective Intrathecal Immunoglobulin M synthesis (IgMIntrathecal Fraction (IF)+) and spinal MRI lesions are both strong independent predictors of higher…”
Get full text
Journal Article -
12
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Published in Annals of neurology (01-09-2021)“…Objective We aimed to determine in relapsing multiple sclerosis (MS) whether intrathecal synthesis of immunoglobulin (Ig) M and IgG is associated with outcomes…”
Get full text
Journal Article -
13
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-09-2023)“…BackgroundGranulocyte invasion into the brain is a pathoanatomical feature differentiating neuromyelitis optica spectrum disorder (NMOSD) from multiple…”
Get full text
Journal Article -
14
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis
Published in JAMA neurology (01-12-2023)“…Mechanisms contributing to disability accumulation in multiple sclerosis (MS) are poorly understood. Blood neurofilament light chain (NfL) level, a marker of…”
Get more information
Journal Article -
15
Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy
Published in Journal of drug targeting (02-01-2016)“…Background: Tumor progression depends on angiogenesis. Vascular endothelial growth factor (VEGF) receptors (VEGFRs) are the main signal transducers that…”
Get full text
Journal Article -
16
Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression (P5-3.016)
Published in NEUROLOGY (25-04-2023)“…Abstract only…”
Get full text
Journal Article Conference Proceeding -
17
Complement Activation Is Associated With Disease Severity in Multiple Sclerosis
Published in Neurology : neuroimmunology & neuroinflammation (01-03-2024)“…Histopathologic studies have identified immunoglobulin (Ig) deposition and complement activation as contributors of CNS tissue damage in multiple sclerosis…”
Get full text
Journal Article -
18
Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair
Published in The Journal of clinical investigation (01-12-2003)“…Acute myelogenous leukemias (AMLs) are genetically heterogeneous and characterized by chromosomal rearrangements that produce fusion proteins with aberrant…”
Get full text
Journal Article -
19
Abstract 5714: Combination of glucagon-like-peptide-1 (GLP-1) receptor targeted therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Neuroendocrine tumors are well vascularized and express specific cell surface markers, such as somatostatin receptors and glucagon-like peptide-1…”
Get full text
Journal Article -
20
Abstract 3634: Selective targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3 expressing cells
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract Angiogenesis is a key process in tumor progression. Angiogenic sprouting involves specification of subpopulations of endothelial cells into tip cells…”
Get full text
Journal Article